August 17, 2026

Ongoing Trials: The EA8231 research study is testing a new treatment for advanced bladder cancer that continues to grow despite standard treatment

This trial aims to find out if the combination of targeted therapy and immunotherapy can provide greater benefit than standard chemotherapy
May 14, 2026

Five ways to enhance the impact of cancer research advocacy across ECOG‑ACRIN: Lisa Beckendorf discusses insights from recent interviews with research leaders

The Cancer Research Advocates Committee is identifying new strategies and opportunities for closer collaboration in the realm of clinical trials